Chemical and Pharmaceutical Bulletin
Online ISSN : 1347-5223
Print ISSN : 0009-2363
ISSN-L : 0009-2363
Bioactive Saponins and Glycosides. XI. Structures of New Dammarane-Type Triterpene Oligoglycosides, Quinquenosides I, II, III, IV, and V, from American Ginseng, the Roots of Panax quinquefolium L.
Masayuki YOSHIKAWAToshiyuki MURAKAMIKenichi YASHIROJohji YAMAHARAHisashi MATSUDAReiko SAIJOHOsamu TANAKA
Author information
JOURNAL FREE ACCESS

1998 Volume 46 Issue 4 Pages 647-654

Details
Abstract

The methanolic extract and 1-butanol-soluble fraction of American ginseng, the roots of Panax quinquefolium L., were found to exhibit a protective effect on liver injury induced by D-galactosamine and lipopolysaccharide. Five new dammarane-type triterpene oligoglycosides called quinquenosides I, II, III, IV, and V were isolated together with fourteen known dammarane-type triterpene oligoglycosides such as chikusetsusaponin IVa, pseudo-ginsenoside-RC1, malonyl-ginsenoside-Rb1, and notoginsenosides-A, -C, and -K from the 1-butanol-soluble fraction. From the ethyl acetate-soluble fraction, four known acetylenic compounds and 6'-O-acetyl ginsenoside-Rg1 were isolated. The structures of quinquenosides I, II, III, IV, and V were determined on the basis of chemical and physicochemical evidence as 3-O-[6-O-(E)-2-butenoyl-β-D-glucopyranosyl(1→2)-β-D-glucopyranosyl]-20-O-(β-D-glucopyranosyl) 20(S)-protopanaxadiol (quinquenoside I), 3-O-[6-O-(E)-2-octenoyl-β-D-glucopyranosyl(1→2)-β-D-glucopyranosyl]-20-O-[β-D-glucopyranosyl(1→6)-β-D-glucopyranosyl]20(S)-protopanaxadiol (quinquenoside II), 3-O-[β-D-glucopyranosyl(1→2)-6-O-acetyl-β-D-glucopyranosyl]-20-O-(β-D-glucopyranosyl) 20(S)-protopanaxadiol (quinquenoside III), 3-O-[β-D-glucopyranosyl(1→2)-β-D-glucopyranosyl]-20-O-[β-D-glucopyranosyl(1→6)-β-D-glucopyranosyl]-3β, 7β, 20(S)-trihydroxydammar-5, 24-diene (quinoquenoside IV), and 3-O-[β-D-glucopyranosyl(1→2)-β-D-glucopyranosyl]-20-O-[α-D-glucopyranosyl(1→4)-β-D-glucopyranosyl(1→6)-β-D-glucopyranosyl]20(S)-protopanaxadiol (quinquenoside V).

Content from these authors
© The Pharmaceutical Society of Japan
Previous article Next article
feedback
Top